[Image source=Yonhap News]

[Image source=Yonhap News]

View original image

The number of domestic Mpox cases has been decreasing since the implementation of vaccination.


The Central Disease Control Headquarters (CDCH) announced on the 3rd that one additional Mpox case was confirmed during the week from the 26th of last month to the 2nd of this month. The new Mpox case was identified as a male Korean national. The total cumulative cases amount to 117.


Mpox cases had exceeded an average of 40 cases per week during April and May, but a clear decline has been observed since last month. Looking at the previous three months, the numbers were 42 in April, 48 in May, and 22 in June.


The health authorities conducted vaccinations targeting high-risk groups for Mpox infection starting May 8. As of the 2nd, the number of people vaccinated against Mpox in Korea is 4,973 for the first dose and 1,429 for the second dose. According to overseas studies investigated by the CDCH, vaccination against Mpox showed an infection prevention effectiveness of 75% after one dose and 86% after two doses compared to unvaccinated individuals. Even a single dose reduced the severe case rate to 2.1%, compared to 7.5% in the unvaccinated group.


The CDCH stated, "Although the number of domestic Mpox cases is decreasing, cases continue to be reported mainly in neighboring countries. We still cannot be complacent," urging adherence to quarantine guidelines and participation in vaccination.



Mpox vaccinations are available free of charge at 129 medical institutions nationwide designated by the health authorities. In the metropolitan area, where the highest number of cases was reported, vaccinations can be received during weekends and weekday evenings as well.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing